Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Bruxelles  >  Biocartis Group NV    BCART   BE0974281132

BIOCARTIS GROUP NV

(BCART)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company usually posts poor financials for mid or long term investments.
  • The company has poor fundamentals for a short-term investment strategy.
Strengths
  • The prospective high growth for the next fiscal years is among the main assets of the company
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
  • Technically, the stock approaches a strong medium-term resistance at EUR 5.02.
  • Low profitability weakens the company.
  • One of the major weak points of the company is its financial situation.
  • The group usually releases earnings worse than estimated.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart
Sector Medical Equipment
1st jan.Capitalisation (M$)Investor Rating
BIOCARTIS GROUP NV-17.66%316
MASIMO CORPORATION55.26%13 511
NOVOCURE LIMITED38.46%11 878
ASAHI INTECC CO., LTD.13.13%8 739
GETINGE AB1.44%5 644
JIANGSU YUYUE MEDICAL EQUIP..37.16%4 264
SHOCKWAVE MEDICAL, INC.121.17%3 328
TACTILE SYSTEMS TECHNOLOGY,..-36.74%830
SI-BONE, INC.2.00%710
SEMLER SCIENTIFIC, INC.57.50%504
I-SENS INC--.--%337
MISONIX, INC.-23.64%247
DAIKEN MEDICAL CO., LTD.-21.92%142
APOLLO ENDOSURGERY, INC.-2.11%72
ELECTROCORE, INC.-6.29%68
More Results
Financials
Sales 2020 44,8 M 53,4 M 53,4 M
Net income 2020 -57,7 M -68,7 M -68,7 M
Net Debt 2020 113 M 135 M 135 M
P/E ratio 2020 -4,32x
Yield 2020 -
Capitalization 266 M 316 M 316 M
EV / Sales 2020 8,45x
EV / Sales 2021 7,23x
Nbr of Employees 499
Free-Float 81,4%
Upcoming event on BIOCARTIS GROUP NV
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability -
P/E ratio -
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes